Compass Therapeutics Inc. Company Profile
NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.02+0.0219 (+2.19%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Compass Therapeutics at a glance
Compass Therapeutics Inc. (NASDAQ: CMPX) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. At a market capitalization of $183.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001738021, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Compass Therapeutics Inc.
- Ticker
- NASDAQ: CMPX
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- Market cap
- $183.69M
- SEC CIK
- 0001738021
Companies similar to Compass Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DTILPrecision BioSciences Inc. | 6.25 | +0.81% | $172.51M | vs CMPX |
| IPHAInnate Pharma S.A. ADS | 1.52 | -4.40% | $169.78M | vs CMPX |
| CGENCompugen Ltd. | 2.15 | -3.15% | $203.66M | vs CMPX |
| CRDLCardiol Therapeutics Inc. Class A | 1.32 | +0.76% | $160.40M | vs CMPX |
| CHRSCoherus Oncology Inc. | 1.01 | -1.94% | $156.05M | vs CMPX |
| TARAProtara Therapeutics Inc. | 2.59 | +1.37% | $153.06M | vs CMPX |
| ALECAlector Inc. | 1.92 | +6.08% | $214.38M | vs CMPX |
| IVVDInvivyd Inc. | 0.7286 | -9.65% | $214.76M | vs CMPX |